These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
639 related items for PubMed ID: 16010437
21. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells. Zhang X, Huang H, Xu Z, Zhan R. Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853 [Abstract] [Full Text] [Related]
22. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Liu ZM, Tseng JT, Hong DY, Huang HS. Biochem J; 2011 Sep 01; 438(2):349-58. PubMed ID: 21649584 [Abstract] [Full Text] [Related]
23. Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells. Park JW, Choi YJ, Jang MA, Baek SH, Lim JH, Passaniti T, Kwon TK. Biochem Biophys Res Commun; 2001 Aug 31; 286(4):726-34. PubMed ID: 11520058 [Abstract] [Full Text] [Related]
24. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. Hsu YL, Cho CY, Kuo PL, Huang YT, Lin CC. J Pharmacol Exp Ther; 2006 Aug 31; 318(2):484-94. PubMed ID: 16632641 [Abstract] [Full Text] [Related]
25. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Calviño E, Estañ MC, Simón GP, Sancho P, Boyano-Adánez Mdel C, de Blas E, Bréard J, Aller P. Biochem Pharmacol; 2011 Dec 01; 82(11):1619-29. PubMed ID: 21889928 [Abstract] [Full Text] [Related]
26. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
27. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, Zhao CJ, Chen YL, Fan HY, Waxman S, Auffray C, Jin G, Chen SJ, Chen Z, Zhang J. Proc Natl Acad Sci U S A; 2005 May 24; 102(21):7653-8. PubMed ID: 15894607 [Abstract] [Full Text] [Related]
29. Investigation of anticancer mechanism of clavulone II, a coral cyclopentenone prostaglandin analog, in human acute promyelocytic leukemia. Huang YC, Guh JH, Shen YC, Teng CM. J Biomed Sci; 2005 May 24; 12(2):335-45. PubMed ID: 15920677 [Abstract] [Full Text] [Related]
30. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM, Hirano T, Oka K. Cancer Chemother Pharmacol; 2003 Jul 24; 52(1):47-58. PubMed ID: 12750841 [Abstract] [Full Text] [Related]
31. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. Anticancer Res; 2006 Jul 24; 26(1A):227-42. PubMed ID: 16475703 [Abstract] [Full Text] [Related]
32. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation. Liu Y, Hock JM, Sullivan C, Fang G, Cox AJ, Davis KT, Davis BH, Li X. J Cell Biochem; 2010 Dec 15; 111(6):1546-55. PubMed ID: 20862710 [Abstract] [Full Text] [Related]
34. An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells. Kumar A, Malik F, Bhushan S, Sethi VK, Shahi AK, Kaur J, Taneja SC, Qazi GN, Singh J. Chem Biol Interact; 2008 Feb 15; 171(3):332-47. PubMed ID: 18070620 [Abstract] [Full Text] [Related]
35. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation. Ho SY, Chen WC, Chiu HW, Lai CS, Guo HR, Wang YJ. Chem Biol Interact; 2009 May 15; 179(2-3):304-13. PubMed ID: 19159621 [Abstract] [Full Text] [Related]
36. Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. Liu J, Hu WX, He LF, Ye M, Li Y. FEBS Lett; 2004 Dec 17; 578(3):245-50. PubMed ID: 15589827 [Abstract] [Full Text] [Related]
37. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Wang W, Adachi M, Zhang R, Zhou J, Zhu D. Pancreas; 2009 May 17; 38(4):e114-23. PubMed ID: 19342982 [Abstract] [Full Text] [Related]
38. Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines. Rojewski MT, Körper S, Thiel E, Schrezenmeier H. Oncol Rep; 2004 Feb 17; 11(2):509-13. PubMed ID: 14719092 [Abstract] [Full Text] [Related]
39. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Woo SH, Park IC, Park MJ, Lee HC, Lee SJ, Chun YJ, Lee SH, Hong SI, Rhee CH. Int J Oncol; 2002 Jul 17; 21(1):57-63. PubMed ID: 12063550 [Abstract] [Full Text] [Related]